Author: Lian, Ningfang; Lin, Su; Xie, Hansheng
Title: Liver injury in COVIDâ€19: diagnosis and associated factors – authors' reply Cord-id: 7eou7six Document date: 2020_5_11
ID: 7eou7six
Snippet: As coronavirus disease 2019 (COVIDâ€19) is a new, emerging infectious disease, guidance or consensus on liver injury are lacking(2). The definition of COVIDâ€19 associated liver injury in our manuscript was as alanine transaminase (ALT), aspartate aminotransferase (AST) or bilirubin above the upper limit of normal (ULN), which were 50 U/L, 40 U/L, and 26 μmol/l respectively. The abnormal test results of ALT, AST and total bilirubin at baseline data were defined as liver injury in our manuscri
Document: As coronavirus disease 2019 (COVIDâ€19) is a new, emerging infectious disease, guidance or consensus on liver injury are lacking(2). The definition of COVIDâ€19 associated liver injury in our manuscript was as alanine transaminase (ALT), aspartate aminotransferase (AST) or bilirubin above the upper limit of normal (ULN), which were 50 U/L, 40 U/L, and 26 μmol/l respectively. The abnormal test results of ALT, AST and total bilirubin at baseline data were defined as liver injury in our manuscript.
Search related documents:
Co phrase search for related documents- liver injury and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
Co phrase search for related documents, hyperlinks ordered by date